Emcure Pharmaceuticals Limited (NSE:EMCURE)

Emcure Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 27, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	246,323	203,202	-	-	-	-
Enterprise Value	256,091	214,615	-	-	-	-
Last Close Price	1299.80	1072.40	-	-	-	-
PE Ratio	35.68	29.82	-	-	-	-
Forward PE	26.34	24.17	-	-	-	-
PS Ratio	3.12	2.57	-	-	-	-
PB Ratio	5.31	4.38	-	-	-	-
P/TBV Ratio	7.04	5.81	-	-	-	-
P/FCF Ratio	39.10	32.26	-	-	-	-
P/OCF Ratio	28.92	23.86	-	-	-	-
PEG Ratio	1.05	0.93	-	-	-	-
EV/Sales Ratio	3.24	2.72	-	-	-	-
EV/EBITDA Ratio	17.43	14.61	-	-	-	-
EV/EBIT Ratio	23.61	19.79	-	-	-	-
EV/FCF Ratio	40.65	34.07	-	-	-	-
Debt / Equity Ratio	0.22	0.22	0.75	0.88	1.05	1.04
Debt / EBITDA Ratio	0.70	0.70	1.91	1.99	1.68	1.93
Debt / FCF Ratio	1.62	1.62	2.84	6.55	5.69	4.26
Asset Turnover	0.99	0.99	0.92	0.94	0.91	0.79
Inventory Turnover	1.79	1.79	1.66	1.54	1.47	1.39
Quick Ratio	0.86	0.86	0.75	0.72	0.51	0.58
Current Ratio	1.71	1.71	1.33	1.27	1.16	1.09
Return on Equity (ROE)	18.23%	18.23%	18.28%	23.59%	31.35%	27.90%
Return on Assets (ROA)	8.45%	8.45%	7.92%	9.04%	10.54%	9.43%
Return on Capital (ROIC)	12.19%	12.19%	10.98%	12.36%	14.80%	13.20%
Return on Capital Employed (ROCE)	19.50%	19.50%	20.00%	25.20%	35.00%	28.40%
Earnings Yield	2.77%	3.35%	-	-	-	-
FCF Yield	2.56%	3.10%	-	-	-	-
Dividend Yield	0.23%	0.28%	-	-	-	-
Payout Ratio	-	-	10.89%	6.80%	8.19%	4.61%
Buyback Yield / Dilution	-3.40%	-3.40%	-0.01%	-	-	-
Total Shareholder Return	-3.17%	-3.12%	-0.01%	-	-	-

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.